BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2986744)

  • 1. Adult T cell leukemia: a potential target for ricin A chain immunotoxins.
    Krönke M; Depper JM; Leonard WJ; Vitetta ES; Waldmann TA; Greene WC
    Blood; 1985 Jun; 65(6):1416-21. PubMed ID: 2986744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective killing of human T-lymphotropic virus-I infected leukemic T-cells by monoclonal anti-interleukin 2 receptor antibody-ricin A chain conjugates: potentiation by ammonium chloride and monensin.
    Krönke M; Schlick E; Waldmann TA; Vitetta ES; Greene WC
    Cancer Res; 1986 Jul; 46(7):3295-8. PubMed ID: 3011246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells.
    Uchiyama T; Hori T; Tsudo M; Wano Y; Umadome H; Tamori S; Yodoi J; Maeda M; Sawami H; Uchino H
    J Clin Invest; 1985 Aug; 76(2):446-53. PubMed ID: 2993359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-2 receptor expression in retrovirus associated adult T-cell leukemia.
    Waldmann TA; Leonard WJ; Depper JM; Krönke M; Goldman CK; Oh T; Greene WC
    Princess Takamatsu Symp; 1984; 15():259-68. PubMed ID: 6100644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interleukin-2 receptor on malignant cells: a target for diagnosis and therapy.
    Waldmann TA
    Cell Immunol; 1986 Apr; 99(1):53-60. PubMed ID: 3019574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal expression of interleukin-2 receptor (Tac antigen) in adult T-cell leukemia.
    Uchiyama T; Wano Y; Tsudo M; Umadome H; Hori T; Tamori S; Uchino H; Yodoi J; Maeda M; Kobayashi N
    Princess Takamatsu Symp; 1984; 15():253-8. PubMed ID: 6100643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
    Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 2 receptor (Tac antigen) expression in HTLV-I-associated adult T-cell leukemia.
    Waldmann TA; Longo DL; Leonard WJ; Depper JM; Thompson CB; Krönke M; Goldman CK; Sharrow S; Bongiovanni K; Greene WC
    Cancer Res; 1985 Sep; 45(9 Suppl):4559s-4562s. PubMed ID: 2990687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of human acute T-cell leukemia in SCID mice using the anti-CD7-deglycosylated ricin A-chain immunotoxin DA7.
    Jansen B; Vallera DA; Jaszcz WB; Nguyen D; Kersey JH
    Cancer Res; 1992 Mar; 52(5):1314-21. PubMed ID: 1371092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor.
    Waldmann TA; Greene WC; Sarin PS; Saxinger C; Blayney DW; Blattner WA; Goldman CK; Bongiovanni K; Sharrow S; Depper JM
    J Clin Invest; 1984 Jun; 73(6):1711-8. PubMed ID: 6327770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of colony assays and anti-T cell immunotoxins to elucidate the immunobiologic features of leukemic progenitor cells in T-lineage acute lymphoblastic leukemia.
    Uckun FM; Myers DE; Ledbetter JA; Swaim SE; Gajl-Peczalska KJ; Vallera DA
    J Immunol; 1988 Mar; 140(6):2103-11. PubMed ID: 3126241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
    Ramakrishnan S; Houston LL
    Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct reactivities of four monoclonal antibodies with human interleukin 2 receptor.
    Tanaka Y; Tozawa H; Hayami M; Sugamura K; Hinuma Y
    Microbiol Immunol; 1985; 29(10):959-72. PubMed ID: 2417094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of anti-Tac and anti-transferrin receptor-conjugated liposomes for specific drug delivery to adult T-cell leukemia.
    Hege KM; Daleke DL; Waldmann TA; Matthay KK
    Blood; 1989 Nov; 74(6):2043-52. PubMed ID: 2679914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interleukin-2 receptor on normal and malignant lymphocytes.
    Waldmann TA
    Adv Exp Med Biol; 1987; 213():129-37. PubMed ID: 2888269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-2- and IL-2-R- independent proliferation of T-cell lines from adult T-cell leukemia/lymphoma patients.
    Katoh T; Harada T; Morikawa S; Wakutani T
    Int J Cancer; 1986 Aug; 38(2):265-74. PubMed ID: 2874115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TCGF(IL 2)-receptor inducing factor(s). II. Possible role of ATL-derived factor (ADF) on constitutive IL 2 receptor expression of HTLV-I(+) T cell lines.
    Okada M; Maeda M; Tagaya Y; Taniguchi Y; Teshigawara K; Yoshiki T; Diamantstein T; Smith KA; Uchiyama T; Honjo T
    J Immunol; 1985 Dec; 135(6):3995-4003. PubMed ID: 2999237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells).
    Yodoi J; Teshigawara K; Nikaido T; Fukui K; Noma T; Honjo T; Takigawa M; Sasaki M; Minato N; Tsudo M
    J Immunol; 1985 Mar; 134(3):1623-30. PubMed ID: 2578514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of interleukin 2 receptors on activated human B cells.
    Waldmann TA; Goldman CK; Robb RJ; Depper JM; Leonard WJ; Sharrow SO; Bongiovanni KF; Korsmeyer SJ; Greene WC
    J Exp Med; 1984 Nov; 160(5):1450-66. PubMed ID: 6092511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult T leukemia cells produce a lymphokine that augments interleukin 2 receptor expression.
    Teshigawara K; Maeda M; Nishino K; Nikaido T; Uchiyama T; Tsudo M; Wano Y; Yodoi J
    J Mol Cell Immunol; 1985; 2(1):17-26. PubMed ID: 2978223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.